DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betaseron (Interferon Beta-1B) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

BETASERON SUMMARY

Betaseron® (Interferon beta-lb) is a purified, sterile, lyophilized protein product produced by recombinant DNA techniques. Interferon beta-1b is manufactured by bacterial fermentation of a strain of Escherichia coli that bears a genetically engineered plasmid containing the gene for human interferon betaser17. The native gene was obtained from human fibroblasts and altered in a way that substitutes serine for the cystine residue found at position 17.

Betaseron (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations.


See all Betaseron indications & dosage >>

BETASERON NEWS HIGHLIGHTS

Published Studies Related to Betaseron (Interferon Beta-1B)

Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers. [2008.08.13]

Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers. [2008.06.17]

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. [2008.04]

Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. [2007.09]

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. [2007.08.04]

more >>

Clinical Trials Related to Betaseron (Interferon Beta-1B)

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [No longer recruiting]

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose [Active, not recruiting]

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [Active, not recruiting]

Betaferon®/ Betaseron® (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy [Completed]

Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) [Active, not recruiting]

more >>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008